KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Total Current Liabilities (2016 - 2025)

CareDx (CDNA) has disclosed Total Current Liabilities for 13 consecutive years, with $89.8 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 0.53% to $89.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.8 million through Dec 2025, up 0.53% year-over-year, with the annual reading at $89.8 million for FY2025, 0.53% up from the prior year.
  • Total Current Liabilities hit $89.8 million in Q4 2025 for CareDx, down from $99.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $99.0 million in Q3 2025 to a low of $45.7 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $76.2 million across 5 years, with a median of $76.6 million in 2021.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 61.45% in 2021 and later fell 5.05% in 2023.
  • Year by year, Total Current Liabilities stood at $77.3 million in 2021, then dropped by 1.72% to $76.0 million in 2022, then grew by 2.76% to $78.1 million in 2023, then rose by 14.47% to $89.4 million in 2024, then rose by 0.53% to $89.8 million in 2025.
  • Business Quant data shows Total Current Liabilities for CDNA at $89.8 million in Q4 2025, $99.0 million in Q3 2025, and $93.2 million in Q2 2025.